A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline

A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline

Abstract Background Eravacycline is a novel fluorocycline approved for treatment of intraabdominal infections, with a broad spectrum of activity against a range of pathogens including multidrug-resistant species, including ESBL- or KPC-producing isolates. It is approved for twice-daily dosing with n...

Full description

Bibliographic Details
Main Authors: Nicholas Van Hise, Russell M. Petrak, Nathan C. Skorodin, Robert M. Fliegelman, Michael Anderson, Vishal Didwania, Alice Han, Kairav Shah, Vishnu Chundi, David Hines, Ingrid Roig, Apoorv Kalra
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-10-01
Series:Infectious Diseases and Therapy
Subjects:
Adverse events
Clinical efficacy
Clostridiodes difficile
Eravacycline
Real-world
Online Access:https://doi.org/10.1007/s40121-020-00351-0

Internet

https://doi.org/10.1007/s40121-020-00351-0

Similar Items